HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
334.61
+6.99 (2.13%)
Jan 30, 2025, 4:00 PM EST - Market closed

HCA Healthcare Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 380.2, with a low estimate of 320 and a high estimate of 440. The average target predicts an increase of 13.62% from the current stock price of 334.61.

Analyst Consensus: Buy
Target Low Average Median High
Price $320 $380.2 $380 $440
Change -4.37% +13.62% +13.57% +31.50%

Analyst Ratings

The average analyst rating for HCA Healthcare stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Aug '24Sep '24Oct '24Nov '24Dec '24Jan '25
Strong Buy 664334
Buy 667667
Hold 566554
Sell 000111
Strong Sell 000000
Total 171817151516

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Maintains
$405$384
Buy Maintains $405$384 +14.76% Jan 27, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$380$370
Strong Buy Maintains $380$370 +10.58% Jan 27, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$405
Buy Reiterates $405 +21.04% Jan 27, 2025
Barclays
Barclays
Buy
Maintains
$392$366
Buy Maintains $392$366 +9.38% Jan 27, 2025
Keybanc
Keybanc
Buy
Maintains
$420$370
Buy Maintains $420$370 +10.58% Jan 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
75.51B
from 70.60B
Increased by 6.94%
Revenue Next Year
79.56B
from 75.51B
Increased by 5.37%
EPS This Year
24.76
from 22.00
Increased by 12.56%
EPS Next Year
27.56
from 24.76
Increased by 11.31%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
51.53B58.75B60.23B64.97B70.60B75.51B79.56B85.15B
Revenue Growth
0.38%14.01%2.52%7.86%8.67%6.94%5.37%7.03%
EPS
10.9321.1619.1518.9722.0024.7627.5631.32
EPS Growth
8.54%93.60%-9.50%-0.94%15.97%12.56%11.31%13.62%
Forward PE
-----13.5112.1410.68
No. Analysts -----26224
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 80.1B 85.3B 90.2B
Avg 75.5B 79.6B 85.2B
Low 71.2B 75.7B 80.2B

Revenue Growth

Revenue Growth 20252026202720282029
High
13.5%
13.0%
13.3%
Avg
6.9%
5.4%
7.0%
Low
0.8%
0.3%
0.8%

EPS Forecast

EPS 20252026202720282029
High 26.79 30.36 33.16
Avg 24.76 27.56 31.32
Low 22.94 24.35 30.07

EPS Growth

EPS Growth 20252026202720282029
High
21.8%
22.6%
20.3%
Avg
12.6%
11.3%
13.6%
Low
4.3%
-1.7%
9.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.